Shivani Agarwal, MD, MPH, Shakira Suglia, ScD, MS, and J. Frank Wharam, MD, MPH, will examine strategies to address risks influenced by social needs and to improve outcomes.
The digital diabetes care market will be worth upward of $700 million in 2022. Anne L. Peters, MD, and Kasia J. Lipska, MD, MHS, BS, will explore whether it is worth the cost.
Jennifer Sherr, MD, PhD, will highlight new glucagon formulations for treatment, and Nicole de Zoysa, DClinPsych, will review the impact of overcoming psychological obstacles on optimal hypoglycemia management.
The average ages of patients who are potentially eligible for pancreas transplantation and of potential organ donors are on the rise, but that is not the only challenge for this sector of the diabetes community, as Eelco J.P. de Koning, MD, PhD, will explain.
Jennifer LeBlanc, CDCES, shares details about this presentation, which begins Friday, June 25, at 12:00 p.m. ET.
Carol A. Shively, PhD, shares details about this presentation, which begins Friday, June 25, at 1:05 p.m. ET.
Ananta Addala, DO, MPH, shares details about this presentation, which begins Saturday, June 26, at 8:25 a.m. ET.
Florin Despa, PhD, shares details about this presentation, which begins Saturday, June 26, at 8:30 a.m. ET.
Muthiah Vaduganathan, MD, MPH, shares details about this presentation, which begins Saturday, June 26, at 8:30 a.m. ET.
Jeffrey R. Millman, PhD, shares details about this presentation, which begins Saturday, June 26, at 1:45 p.m. ET.